ETF Holdings Breakdown of PRTA

Stock NameProthena Corporation plc
TickerPRTA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINIE00B91XRN20

News associated with PRTA

Hsbc Holdings PLC Grows Holdings in Prothena Co. plc (NASDAQ:PRTA)
Hsbc Holdings PLC increased its stake in shares of Prothena Co. plc (NASDAQ:PRTA – Free Report) by 60.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 24,179 shares of the biotechnology company’s stock after purchasing an additional 9,101 shares during the period. Hsbc Holdings PLC’s holdings […] - 2025-05-09 08:41:02
Renaissance Technologies LLC Acquires 19,100 Shares of Prothena Co. plc (NASDAQ:PRTA)
Renaissance Technologies LLC increased its holdings in shares of Prothena Co. plc (NASDAQ:PRTA – Free Report) by 10.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 201,900 shares of the biotechnology company’s stock after purchasing an additional 19,100 shares during the period. […] - 2025-04-25 08:54:49
Corebridge Financial Inc. Trims Position in Prothena Co. plc (NASDAQ:PRTA)
Corebridge Financial Inc. trimmed its position in Prothena Co. plc (NASDAQ:PRTA – Free Report) by 7.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,140 shares of the biotechnology company’s stock after selling 1,596 shares during the quarter. […] - 2025-04-11 08:40:59
Prothena Co. plc (NASDAQ:PRTA) Given Consensus Rating of “Moderate Buy” by Analysts
Prothena Co. plc (NASDAQ:PRTA – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eight analysts that are presently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month price target among […] - 2025-04-11 07:32:50
KLP Kapitalforvaltning AS Acquires New Shares in Prothena Co. plc (NASDAQ:PRTA)
KLP Kapitalforvaltning AS acquired a new position in Prothena Co. plc (NASDAQ:PRTA – Free Report) in the fourth quarter, HoldingsChannel reports. The fund acquired 12,900 shares of the biotechnology company’s stock, valued at approximately $179,000. Several other hedge funds and other institutional investors also recently added to or reduced their stakes in PRTA. Orion Portfolio […] - 2025-04-09 07:28:47
Prothena Co. plc (NASDAQ:PRTA) Shares Acquired by Rhumbline Advisers
Rhumbline Advisers grew its stake in Prothena Co. plc (NASDAQ:PRTA – Free Report) by 1.8% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 67,115 shares of the biotechnology company’s stock after buying an additional 1,175 shares during the period. Rhumbline Advisers’ holdings in Prothena were worth $930,000 as of its most recent filing […] - 2025-03-07 08:24:49
Prothena (NASDAQ:PRTA) Raised to “Hold” at StockNews.com
Prothena (NASDAQ:PRTA – Get Free Report) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday. PRTA has been the topic of several other research reports. Oppenheimer lifted their price objective on Prothena from $58.00 to $62.00 and gave the stock an […] - 2025-02-26 06:52:50
Prothena Co. plc (NASDAQ:PRTA) Receives Average Rating of “Moderate Buy” from Analysts
Prothena Co. plc (NASDAQ:PRTA – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven brokerages that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12-month target price among […] - 2025-02-25 08:38:51
Prothena (NASDAQ:PRTA) Earns Buy Rating from HC Wainwright
Prothena (NASDAQ:PRTA – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a research note issued to investors on Friday,Benzinga reports. They currently have a $48.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective would suggest a potential upside of 208.48% from the company’s previous […] - 2025-02-23 10:17:01
Prothena (NASDAQ:PRTA) & Annexon (NASDAQ:ANNX) Critical Comparison
Prothena (NASDAQ:PRTA – Get Free Report) and Annexon (NASDAQ:ANNX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership. Analyst Ratings This is a summary of current ratings […] - 2025-02-13 08:26:51
Head to Head Review: Prothena (NASDAQ:PRTA) and KALA BIO (NASDAQ:KALA)
Prothena (NASDAQ:PRTA – Get Free Report) and KALA BIO (NASDAQ:KALA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, analyst recommendations, profitability, institutional ownership and valuation. Earnings & Valuation This table compares Prothena and […] - 2025-02-12 06:27:08
Prothena (NASDAQ:PRTA) Price Target Raised to $62.00
Prothena (NASDAQ:PRTA – Free Report) had its price target boosted by Oppenheimer from $58.00 to $62.00 in a report published on Friday,Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. Several other equities analysts have also recently issued reports on the stock. Chardan Capital started coverage on shares of Prothena in […] - 2025-02-10 17:04:47
China Universal Asset Management Co. Ltd. Acquires 1,065 Shares of Prothena Co. plc (NASDAQ:PRTA)
China Universal Asset Management Co. Ltd. boosted its holdings in shares of Prothena Co. plc (NASDAQ:PRTA – Free Report) by 10.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,409 shares of the biotechnology company’s stock after acquiring an additional […] - 2025-02-04 09:03:03

PRTA institutional holdings

The following institutional investment holdings of PRTA have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 28,784USD 204,366 -2.7%
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 67,102USD 476,424 -2.7%
2025-05-08 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 68,218USD 484,348 -2.7%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 25,748USD 182,811
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 25,748USD 182,811 -2.7%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,713USD 12,162 -2.7%
Total =217,313 USD 1,542,922
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.